CHARLES RIVER LABORATORIES (CRL) Stock Earnings Estimates
NYSE:CRL • US1598641074
161.35 USD
+2.61 (+1.64%)
At close: Feb 13, 2026
161.35 USD
0 (0%)
After Hours: 2/13/2026, 8:04:00 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 3.976B 12.31% | 4.129B 3.86% | 4.05B -1.92% | 4.047B -0.07% | 4.116B 1.70% | 4.308B 4.66% | 4.446B 3.20% | 4.556B 2.47% | 4.75B 4.26% | 4.922B 3.62% | 5.134B 4.31% | 5.361B 4.42% | |
| EBITDA YoY % growth | 963.585M 7.24% | 973.446M 1.02% | 912.573M -6.25% | 995.29M 9.06% | 1.008B 1.28% | 1.07B 6.15% | 1.131B 5.70% | 1.23B 8.75% | 1.124B -8.62% | 1.388B 23.49% | 1.47B 5.91% | 1.56B 6.12% | |
| EBIT YoY % growth | 659.715M 4.22% | 659.322M -0.06% | 550.832M -16.45% | 787.93M 43.04% | 805.49M 2.23% | 858.12M 6.53% | 923.21M 7.59% | 985.73M 6.77% | 1.059B 7.43% | N/A | N/A | N/A | |
| Operating Margin | 16.59% | 15.97% | 13.60% | 19.47% | 19.57% | 19.92% | 20.76% | 21.64% | 22.29% | N/A | N/A | N/A | |
| EPS YoY % growth | 11.13 7.74% | 10.65 -4.31% | 10.32 -3.10% | 10.34 0.16% | 10.99 6.29% | 12.21 11.12% | 12.95 6.06% | 14.44 11.54% | 15.60 8.01% | 29.52 89.25% | N/A | N/A |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 2.37 -11.02% | 2.58 10.37% | 2.88 -7.74% | 2.77 13.94% | 2.74 15.79% | 2.84 9.88% | 2.94 2.13% | 3.00 8.23% | 3.00 9.44% |
| Revenue Q2Q % growth | 996.87M -0.57% | 1.006B 2.22% | 1.043B 1.05% | 1.035B 3.00% | 1.029B 3.22% | 1.06B 5.37% | 1.082B 3.74% | 1.092B 5.51% | 1.094B 6.32% |
| EBITDA Q2Q % growth | 227.62M -49.63% | 241.53M 10.35% | 257.75M -30.75% | 255.8M -46.27% | 250.33M 9.98% | 261.22M 8.15% | 267.83M 3.91% | 275.61M 7.74% | 274.35M 9.60% |
| EBIT Q2Q % growth | 182.21M 102.01% | 197.28M 100.26% | 218.77M 65.32% | 211.26M 39.83% | 200.64M 10.11% | 209.92M 6.41% | 217.2M -0.72% | 216.34M 2.40% | 208.12M 3.73% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 2.43 -6.18% | 2.36 | 0.07 | 2.88% |
| Q2 2025 Q2Q % growth | 3.12 11.43% | 2.52 | 0.60 | 23.68% |
| Q1 2025 Q2Q % growth | 2.34 3.08% | 2.10 | 0.24 | 11.44% |
| Q4 2024 Q2Q % growth | 2.66 8.13% | 2.56 | 0.10 | 4.03% |
| Q3 2024 Q2Q % growth | 2.59 -4.78% | 2.45 | 0.14 | 5.70% |
| Q2 2024 Q2Q % growth | 2.80 4.09% | 2.42 | 0.38 | 15.80% |
| Q1 2024 Q2Q % growth | 2.27 -18.35% | 2.09 | 0.18 | 8.63% |
| Q4 2023 Q2Q % growth | 2.46 -17.45% | 2.43 | 0.03 | 1.38% |
| Q3 2023 Q2Q % growth | 2.72 3.42% | 2.39 | 0.33 | 13.71% |
| Q2 2023 Q2Q % growth | 2.69 -2.89% | 2.66 | 0.03 | 0.95% |
| Q1 2023 Q2Q % growth | 2.78 1.09% | 2.61 | 0.17 | 6.34% |
| Q4 2022 Q2Q % growth | 2.98 19.68% | 2.77 | 0.21 | 7.46% |
| Q3 2022 Q2Q % growth | 2.63 -2.59% | 2.52 | 0.11 | 4.37% |
| Q2 2022 Q2Q % growth | 2.77 6.13% | 2.76 | 0.01 | 0.30% |
| Q1 2022 Q2Q % growth | 2.75 8.70% | 2.74 | 0.01 | 0.26% |
| Q4 2021 Q2Q % growth | 2.49 4.18% | 2.46 | 0.03 | 1.35% |
| Q3 2021 Q2Q % growth | 2.70 15.88% | 2.60 | 0.10 | 3.70% |
| Q2 2021 Q2Q % growth | 2.61 65.19% | 2.40 | 0.21 | 8.57% |
| Q1 2021 Q2Q % growth | 2.53 37.50% | 2.21 | 0.32 | 14.27% |
| Q4 2020 Q2Q % growth | 2.39 | 2.13 | 0.26 | 12.40% |
| Q3 2020 Q2Q % growth | 2.33 | 1.82 | 0.51 | 28.20% |
| Q2 2020 Q2Q % growth | 1.58 | 1.28 | 0.30 | 23.72% |
| Q1 2020 Q2Q % growth | 1.84 | 1.50 | 0.34 | 22.89% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 1.005B -0.49% | 1.001B | 3.852M | 0.38% |
| Q2 2025 Q2Q % growth | 1.032B 0.59% | 994.91M | 37.225M | 3.74% |
| Q1 2025 Q2Q % growth | 984.168M -2.71% | 951.39M | 32.778M | 3.45% |
| Q4 2024 Q2Q % growth | 1.003B -1.08% | 993.46M | 9.089M | 0.91% |
| Q3 2024 Q2Q % growth | 1.01B -1.64% | 985.77M | 23.993M | 2.43% |
| Q2 2024 Q2Q % growth | 1.026B -3.19% | 1.035B | -8.883M | -0.86% |
| Q1 2024 Q2Q % growth | 1.012B -1.73% | 1.002B | 9.56M | 0.95% |
| Q4 2023 Q2Q % growth | 1.013B -7.85% | 1.001B | 12.476M | 1.25% |
| Q3 2023 Q2Q % growth | 1.027B 3.79% | 1.011B | 15.623M | 1.55% |
| Q2 2023 Q2Q % growth | 1.06B 8.92% | 1.064B | -4.063M | -0.38% |
| Q1 2023 Q2Q % growth | 1.029B 12.63% | 996.21M | 33.163M | 3.33% |
| Q4 2022 Q2Q % growth | 1.1B 21.52% | 1.045B | 54.843M | 5.25% |
| Q3 2022 Q2Q % growth | 989.157M 10.40% | 980.14M | 9.017M | 0.92% |
| Q2 2022 Q2Q % growth | 973.131M 6.40% | 1.005B | -31.869M | -3.17% |
| Q1 2022 Q2Q % growth | 913.929M 10.83% | 919.21M | -5.281M | -0.57% |
| Q4 2021 Q2Q % growth | 905.05M 14.42% | 897.16M | 7.89M | 0.88% |
| Q3 2021 Q2Q % growth | 895.937M 20.54% | 912.23M | -16.293M | -1.79% |
| Q2 2021 Q2Q % growth | 914.607M 33.99% | 889.25M | 25.357M | 2.85% |
| Q1 2021 Q2Q % growth | 824.6M 16.62% | 806.16M | 18.44M | 2.29% |
| Q4 2020 Q2Q % growth | 791M | 764.43M | 26.57M | 3.48% |
| Q3 2020 Q2Q % growth | 743.3M | 724.05M | 19.25M | 2.66% |
| Q2 2020 Q2Q % growth | 682.6M | 645.71M | 36.89M | 5.71% |
| Q1 2020 Q2Q % growth | 707.1M | 697.6M | 9.5M | 1.36% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0.01% | -0.01% | 0.47% |
| Revenue | -0.02% | 0.05% | -0.02% | 0.4% |